Evaluation of the Charlson Comorbidity Index to Predict Early Mortality in Implantable Cardioverter Defibrillator Patients

Author： Bhavnani Sanjeev P. Coleman Craig I. Guertin Danette Yarlagadda Ravi K. Clyne Christopher A. Kluger Jeffrey

Publisher： Blackwell Publishing

ISSN： 1082-720X

Source： Annals of Noninvasive Electrocardiology, Vol.18, Iss.4, 2013-07, pp. : 379-388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?

By Nault Michael A. McIntyre William F. Simpson Christopher S. Redfearn Damian P. Abdollah Hoshiar Brennan F. James Baranchuk Adrian

Annals of Noninvasive Electrocardiology, Vol. 15, Iss. 2, 2010-04 ,pp. : 181-183

Blackwell Publishing

Access to resources Recommend Favorite

Cost Effectiveness of Implantable Cardioverter Defibrillator Therapy versus Drug Therapy for Patients at High Risk of Sudden Cardiac Death

By Spath M.A.

PharmacoEconomics, Vol. 20, Iss. 11, 2002-01 ,pp. : 727-738

Adis International

Access to resources Recommend Favorite

New evidence supports the use of implantable cardioverter defibrillators (ICDs) to reduce all-cause mortality among primary prevention patients.

Inpharma, Vol. 1, Iss. 1604, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Antiarrhythmic Drugs in Patients with Implantable Cardioverter-Defibrillators

By Bollmann Andreas Husser Daniela Cannom David S.

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 6, 2005-01 ,pp. : 371-378

Adis International

Access to resources Recommend Favorite

Dertnatologic Electrosurgery in Patients with Implantable Cardioverter-Defibrillators and Pacemakers

By LeVASSEUR MAJOR JOHN G. KENNARD CHARLES D. FINLEY MAJOR ERIC M. MUSE MAJOR ROGER K.

Dermatologic Surgery, Vol. 24, Iss. 2, 1998-02 ,pp. : 233-240

Elsevier

Access to resources Recommend Favorite